The team analyzed electronic health records of 606,434 U.S
doi: 10.3803/EnM.2021.102 Summary Keywords GLP-1 receptor agonists, endocrine, cardiovascular, neurological, cancer Citation Zhao X, Wang M, Wen Z, Lu Z, Cui L, Fu C, Xue H, Liu Y and Zhang Y (2021) GLP-1 Receptor Agonists: Beyond Their Pancreatic Effects
Drawing lessons from other countries approaches to covering GLP-1 drugs, LDI Senior Fellow Ezekiel Emanuel and colleagues give four key guidelines that should inform future policies to ensure fair and effective access to these critical medications across the U.S
When patients report that they can barely eat, encourage them to try at least three small meals or snacks each day, even if portions are tiny (you could also consider reducing the dose of the medication, of course)
Frontiers in Nutrition, 2025, DOI: 10.3389/fnut.2025.1566498,